Hedge Fund - Woodline Partners
Revolution Medicines Inc. (RVMD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $199,196,287 | 0.77% | 2,500,895 | $65.57 |
| 2 | 2025 - Q3 (2025-09-30) | $136,171,736 | 0.64% | 2,915,883 | $39.15 |
| 3 | 2025 - Q2 (2025-06-30) | $107,263,894 | 0.57% | 2,915,572 | $38.42 |
| 4 | 2025 - Q1 (2025-03-31) | $137,445,593 | 0.89% | 3,887,036 | $40.59 |
| 5 | 2024 - Q4 (2024-12-31) | $169,961,087 | 1.14% | 3,885,713 | $50.47 |
| 6 | 2024 - Q3 (2024-09-30) | $155,718,885 | 1.31% | 3,433,713 | $43.54 |
| 7 | 2024 - Q2 (2024-06-30) | $127,715,599 | 1.21% | 3,290,791 | $37.38 |
| 8 | 2024 - Q1 (2024-03-31) | $122,382,080 | 1.12% | 3,797,148 | $29.64 |
| 9 | 2023 - Q4 (2023-12-31) | $84,893,947 | 0.92% | 2,960,040 | $24.03 |
| 10 | 2023 - Q3 (2023-09-30) | $87,065,918 | 1.02% | 3,145,445 | $29.66 |
| 11 | 2023 - Q2 (2023-06-30) | $100,616,781 | 1.19% | 3,761,375 | $24.54 |
| 12 | 2023 - Q1 (2023-03-31) | $74,141,574 | 1% | 3,422,972 | $24.62 |
| 13 | 2022 - Q4 (2022-12-31) | $10,719,357 | 0.14% | 450,015 | $21.26 |
| 14 | 2022 - Q3 (2022-09-30) | $11,120,000 | 0.15% | 563,881 | $21.98 |
| 15 | 2022 - Q2 (2022-06-30) | $5,141,000 | 0.07% | 263,799 | $19.47 |
| 16 | 2022 - Q1 (2022-03-31) | $59,474,000 | 0.96% | 2,331,395 | $21.77 |
| 17 | 2021 - Q4 (2021-12-31) | $73,749,000 | 1.05% | 2,930,038 | $28.18 |
| 18 | 2021 - Q3 (2021-09-30) | $23,920,000 | 0.39% | 869,484 | $29.11 |
| 19 | 2021 - Q2 (2021-06-30) | $27,030,000 | 0.5% | 851,592 | $34.90 |
| 20 | 2021 - Q1 (2021-03-31) | $38,634,000 | 0.85% | 842,062 | $44.84 |
| 21 | 2020 - Q4 (2020-12-31) | $31,954,000 | 0.84% | 807,130 | $39.54 |
| 22 | 2020 - Q3 (2020-09-30) | $971,000 | 0.03% | 27,911 | $27.70 |
| 23 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $31.44 |
| 24 | 2020 - Q1 (2020-03-31) | $1,202,000 | 0.08% | 54,867 | $27.68 |
The displayed share prices are average quarterly stock market prices.